top of page


Life Sciences Investors React To Biden Administration’s March-In Decision
After a nine-month review, the Biden administration has reached the unprecedented and misguided conclusion that the 1980 Bayh-Dole Act...
Incubate Coalition
Dec 7, 2023


What Is Up For Biopharmaceutical Policy In 2024?
Incubate and DLA Piper invite you to join us on the morning of Sunday, January 7th, as part of JPM Week 2024. Attendees will gain an...
Incubate Coalition
Nov 20, 2023


Mary R. Grealy On The Small Molecule Penalty, U.S. Dominance In Life Sciences, And More
Incubate Executive Director John Stanford sat down this week with Mary R. Grealy, CEO of the Healthcare Leadership Council, to discuss...
Incubate Coalition
Oct 11, 2023


Incubate Releases Statement On Fitch Ratings’ Analysis Of Medicare Drug Price Negotiations
Fitch Ratings recently released an analysis showing that Medicare's drug price negotiation program is expected to deter investments into...
Incubate Coalition
Sep 25, 2023


Medicare Presses Forward With Drug Price Setting
In late August, the Centers for Medicare & Medicaid Services announced the first 10 drugs that will be subject to Medicare price setting...
Incubate Coalition
Sep 17, 2023


Mohit Manrao Talks Small-Molecule Penalty, Eliminating Cancer As A Cause Of Death, And More
The small-molecule penalty "doesn't create the right incentives for where we want to go with the Cancer Moonshot or driving cures," Mohit...
Incubate Coalition
Sep 14, 2023
bottom of page
